1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling
(
- Contribution to journal › Article
- 2019
-
Mark
Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cells
(
- Contribution to journal › Article
- 2018
-
Mark
WNT5A as a therapeutic target in breast cancer
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?
(
- Contribution to journal › Scientific review